---
document_datetime: 2023-09-21 19:53:55
document_pages: 10
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/nonafact-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: nonafact-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 6.8083035
conversion_datetime: 2025-12-30 09:58:12.911381
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Nonafact

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                              | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended no no   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|------------------------------------------------|----------------------------------|-----------|
| IB/0062              | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                     | 24/11/2016 product product          | on                                             | SmPC, Annex II, Labelling and PL |           |
| IAIN/0061            | B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP Medicinal Medicinal | 30/08/2016                          | n/a                                            |                                  |           |

<!-- image -->

Medicinal product no longer authorised

Medicinal product no longer authorised

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

| IB/0059/G   | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                            | 20/05/2016                 | n/a authorised        |                                     |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------|-----------------------|-------------------------------------|
| II/0054     | B.I.a.1.e - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The change relates to a biological AS or a starting material [-] used in the manufacture of a biological/immunological product                                                                                                                                                                                                            | 28/04/2016                 | n/a longer authorised |                                     |
| IAIN/0058/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release Medicinal Medicinal | 22/03/2016 product product | Annex II no no longer |                                     |
| IAIN/0060/G | This was an application for a group of variations. B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - when changes                                                                                                                                                                                                                         | 09/03/2016                 | n/a                   | Inclusion of an updated/amended PMF |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|             | do not affect the properties of the FP B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP                       |                                                        |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------|
| IA/0057     | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                | 03/02/2016 n/a authorised authorised                   |
| T/0055      | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                         | 15/12/2015 28/01/2016 SmPC, Labelling PL longer longer |
| IA/0056     | B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method                                                                                                               | 07/01/2016 n/a no no                                   |
| IAIN/0053   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location Medicinal                                                                                                                                   | 08/12/2015 n/a product product                         |
| IAIN/0052/G | This was an application for a group of variations. B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP Medicinal | 09/04/2015 n/a                                         |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | - Minor changes to an test procedure                                                                                                                                                                                                           |                    |                                 | material/reagent/intermediate approved   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|---------------------------------|------------------------------------------|
| IB/0049   | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                         | 18/02/2015         | n/a                             |                                          |
| IA/0050   | B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, if an alternative test                                            | 22/01/2015         | n/a                             | procedure is already authorised          |
| IAIN/0051 | B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP | 19/01/2015         | n/a product no longer no longer |                                          |
| IB/0048   | B.II.b.1.z - Replacement or addition of a manufacturing site for the FP - Other variation                                                                                                                                                      | 10/12/2014 product | n/a                             |                                          |
| IAIN/0047 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location Medicinal Medicinal                                                            | 19/11/2014         | n/a                             |                                          |
| IAIN/0046 | B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP | 10/06/2014         | n/a                             |                                          |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| PSUSA/1617/ 201307   | Periodic Safety Update EU Single assessment - HUMAN COAGULATION FACTOR IX                                                                                                                                                                                                                                                                                                                                                                                                                                 | 06/03/2014                 | n/a              | PRAC Recommendation - maintenance   |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------|------------------|-------------------------------------|
| IAIN/0045/G          | This was an application for a group of variations. B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes | 27/02/2014                 | n/a longer       | authorised authorised               |
| IB/0043              | B.I.z - Quality change - Active substance - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                               | 15/11/2013                 | n/a no no longer |                                     |
| IB/0041              | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                                                                                                                                                                                                                                                                                    | 18/10/2013 product product | n/a              |                                     |
| IB/0042              | B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation Medicinal Medicinal                                                                                                                                                                                                                                                                                                                                                                           | 08/10/2013                 | n/a              |                                     |
| IA/0040              | B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits                                                                                                                                                                                                                                                                                                                                                                | 24/05/2013                 | n/a              |                                     |
| IB/0039              | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of                                                                                                                                                                                                                                                                                                                                                                                                 | 23/05/2013                 | n/a              |                                     |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|             | the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                            |                  |                                               |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------|------------------|-----------------------------------------------|
| IAIN/0038/G | This was an application for a group of variations. B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes | 25/01/2013                 | n/a longer       | do not affect the properties of the FP        |
| IB/0036/G   | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an Medicinal                                                                                                                     | 01/10/2012 product product | n/a no no longer | approved test procedure                       |
| IAIN/0037/G | This was an application for a group of variations. B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP or Medicinal                                                                                                                                                                                            | 21/09/2012                 | n/a              | B.V.a.1.d - PMF - Inclusion of a new, updated |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | PMF in the marketing authorisation dossier a medicinal product. (PMF 2nd step procedure) - of an updated/amended PMF when changes not affect the properties of the FP                                                                            |                            |                      | amended of Inclusion do                |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------|----------------------|----------------------------------------|
| IAIN/0035 | B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP   | 25/05/2012                 | n/a                  |                                        |
| IA/0034   | B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP   | 04/05/2012                 | n/a no longer longer |                                        |
| IB/0033   | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                 | 21/03/2012 product product | n/a no               |                                        |
| II/0032   | To replace a release test of the drug product. B.II.d.2.c - Change in test procedure for the finished product - Replacement of a biological/ immunological/immunochemical test method or a method using a biological reagent Medicinal Medicinal | 15/03/2012                 | n/a                  |                                        |
| II/0031   | Changes in the test method for \"Activated Factor IX\" and finished product release specifications. B.II.d.2.c - Change in test procedure for the finished                                                                                         | 20/10/2011                 | 20/10/2011           | product - Replacement of a biological/ |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | immunological/immunochemical test method or a method using a biological reagent                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                    |                  |                                  |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|------------------|----------------------------------|
| IB/0030/G | This was an application for a group of variations. B.V.a.1.b - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - First-time inclusion of a new PMF NOT affecting the properties of the FP B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP | 23/09/2011         | n/a              | longer authorised authorised     |
| IB/0029   | B.II.b.3.z - Change in the manufacturing process of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                        | 19/04/2011 product | n/a no no longer |                                  |
| IA/0027   | B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP Medicinal Medicinal                                                                                                                                                                                                                                                                | 13/07/2010 product | n/a              |                                  |
| IB/0026   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                    | 18/06/2010         | n/a              | SmPC, Annex II, Labelling and PL |
| 2PMF/0025 | Inclusion of the updated or amended Plasma Master File (Sanquin EMEA/H/PMF/000007/04) in the marketing authorisation dossier                                                                                                                                                                                                                                                                                                                                                                                                      | 04/05/2009         | n/a              |                                  |

<div style=\"page-break-after: always\"></div>

| IB/0024   | IB_38_c_Change in test procedure of finished product - other changes                                                                  | 16/04/2009                 | n/a              |                                  |                                                                                                                                                                                                                           |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------|----------------------------|------------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0023   | IA_25_b_01_Change to comply with Ph. - compliance with EU Ph. update - active substance                                               | 19/02/2009                 | n/a              |                                  |                                                                                                                                                                                                                           |
| II/0022   | Changes in the in-process controls of the drug product Change(s) to the test method(s) and/or specifications for the finished product | 25/09/2008                 | 02/10/2008       | authorised                       | authorised                                                                                                                                                                                                                |
| MF/0021   | 2PMF (2nd step of PMF certification procedure)                                                                                        | 01/07/2008                 | n/a              |                                  |                                                                                                                                                                                                                           |
| IB/0020   | Change in the reference standard IB_38_b_Change in test procedure of finished product - minor change, biol. active subst./excipient   | 15/01/2008                 | n/a no no longer | longer                           |                                                                                                                                                                                                                           |
| II/0017   | Update of Summary of Product Characteristics and Package Leaflet                                                                      | 24/05/2007 product product | 30/10/2007       | SmPC and PL                      | Update of Section 4.4 and 4.8 of the SPC to bring them in line with the Note for Guidance on the Warning on Transmissible Agents for Plasma-derived medicinal products. The Package Leaflet has been updated accordingly. |
| II/0016   | Quality changes                                                                                                                       | 19/07/2007                 | 24/07/2007       |                                  |                                                                                                                                                                                                                           |
| MF/0018   | 2PMF (2nd step of PMF certification procedure)                                                                                        | 16/05/2007                 | n/a              |                                  |                                                                                                                                                                                                                           |
| IA/0019   | IA_25_b_01_Change to comply with Ph. - compliance with EU Ph. update - active substance Medicinal Medicinal                           | 07/05/2007                 | n/a              |                                  |                                                                                                                                                                                                                           |
| R/0012    | Renewal of the marketing authorisation.                                                                                               | 01/06/2006                 | 25/07/2006       | SmPC, Annex II, Labelling and PL | The renewal was granted with unlimited validity, with a PSUR cycle of 3 years.                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| MF/0013   | 2PMF (2nd step of PMF certification procedure)                                                                                                                                                                               | 20/07/2006                 | n/a                     |                        |                                                                                                                                                                                              |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------|-------------------------|------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0011   | Quality changes                                                                                                                                                                                                              | 23/03/2006                 | 28/03/2006              |                        |                                                                                                                                                                                              |
| MF/0009   | 2PMF (2nd step of PMF certification procedure)                                                                                                                                                                               | 25/01/2006                 | n/a                     |                        |                                                                                                                                                                                              |
| II/0008   | Quality changes                                                                                                                                                                                                              | 14/12/2005                 | 21/12/2005              |                        |                                                                                                                                                                                              |
| IA/0007   | IA_28_Change in any part of primary packaging material not in contact with finished product                                                                                                                                  | 12/04/2005                 | n/a                     | authorised             | The MAH applied to change the colour of the sealing cap from red (article code 06-066) to turquoise (article code 06-070). The sealing cap does not contact the finished product. authorised |
| N/0006    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                             | 16/12/2004                 | n/a                     | PL longer              | The MAH applied to update the list of local representatives to include the accession countries.                                                                                              |
| II/0005   | Update of or change(s) to the pharmaceutical documentation                                                                                                                                                                   | 21/01/2004                 | 26/01/2004 no no longer |                        |                                                                                                                                                                                              |
| I/0003    | 24_Change in test procedure of active substance 25_Change in test procedures of the medicinal product 24a_Change in test procedure for starting material/intermediate used in manuf. of active substance Medicinal Medicinal | 24/07/2003 product product | 05/08/2003              |                        |                                                                                                                                                                                              |
| I/0002    | 25_Change in test procedures of the medicinal product                                                                                                                                                                        | 08/05/2003                 | 14/05/2003              |                        |                                                                                                                                                                                              |
| I/0001    | 03_Change in the name and/or address of the marketing authorisation holder                                                                                                                                                   | 04/04/2003                 | 12/05/2003              | SmPC, Labelling and PL |                                                                                                                                                                                              |